reduce basal insulin dose when starting glp-1 receptor agonist Adding a was not associated with a lower likelihood of discontinuing existing therapy among veterans with type 2 diabetes compared with other glucose-lowering agents, a target emulation Frontiers | Glucagon-like peptide-1 receptor

Drugs like semaglutide and liraglutide have recently gained massive attention not just for diabetes, but for weight loss

This analysis of survey data finds that over 40% of adults under 65 with private insurance could be indicated for a GLP-1 drug though relatively few have a claim, suggesting that a much smaller share seeks treatment through healthcare providers.

CMS GLP-1 Bridge Program: Medicare Part D coverage for weight-loss GLP-1 drugs starting July 1, 2026, including eligibility, covered medications, prior authorization, and copay rules.

Most Americans about 92% have health insurance, either at work, through Medicare or Medicaid, or an individual Affordable Care Act (ACA) plan